Inhibikase Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.76

-0.10 (-5.38%)

As of May 16, 2:06 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,491.5% upside

Low Target $19.41

Average Target $28.01

High Target $39.32

Current Price $1.76

Current
$1.76

Target
$28.01

$19.41 $28.01 avg $39.32

Scenario Analysis

Bear Case

$19.41

1,002.8%

Low target

Base Case

$28.01

+1,491.5%

Avg target

Bull Case

$39.32

+2,134.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.27

-22.5% from high

52-Week Low

$1.33

+32.3% from low

Target vs 52W High

$28.01

+1,133.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%